The percentage of Th17 cells (CD4+ IL-17+) in tumor-bearing mice was significantly lower, whereas the percentage of Tregs (CD25+ Foxp3+) in tumor-bearing mice was higher at 3, 5 and 7 weeks after LLC inoculation than that in Control (Figure 2A–2D). This evidence concerns the gene IL17A and neoplasm.